Items tagged with Research and development

India leads BRICS countries in R&D to eliminate TB, says study (post)

India has poured the highest amount of funds into research to eliminate TB among BRICS nations, a study has found.

TB research briefing for UN Missions - videos now available online (post)

A TB research briefing for UN Missions in New York City on 4 June 2018 provided an opportunity for discussion on the importance of investing in the full spectrum of TB research, and adopting principles to guide research to ensure efficiency and equitable access. The event featured Dr. Soumya Swaminathan, Deputy Director-General for Programs, World Health Organization, as the keynote speaker and then had three panels.

Novartis drops antibiotics research program, ceasing work on several experimental antimicrobial projects (post)

Strengthening TB research in NIAID's TB Strategic Plan (post)

July 17, 2018 – Treatment Action Group (TAG) submitted comments to the National Institute of Allergy and Infectious Diseases (NIAID) at the U.S. National Institutes of Health (NIH) in response to a public request for information (RFI) to inform NIAID's TB Strategic Plan on supporting TB research and development (R&D).

Effective TB, HIV and malaria vaccines missing from drug development pipeline (post)

Many of the vaccines critically needed to fight some of the world’s most prevalent infectious diseases are not likely to be developed, a new analysis of current candidates in the research and development pipeline has found.

Johnson & Johnson announces 10-year initiative to help end TB, the world’s #1 infectious killer (post)

J&J’s goal is to save an estimated 1.8 million lives and prevent 12 million new TB infections.

UK pledges funding to speed up TB treatment (post)

The UK government has pledged £7.5million for the development of three new treatments for tuberculosis, the world's biggest infectious disease killer.

IAVI acquires Aeras TB vaccine clinical programs and assets (post)

Data from two Phase II clinical trials conducted by Aeras and partners indicate promise for future of TB vaccine development.

Call for proposals: Community Representative Grant for TB Drug R&D (post)

To support community engagement, the Stop TB Partnership's Working Group on New TB Drugs (WGND) will provide a one-year grant to support small scale community initiatives that will enhance and increase community engagement and input into TB drug research & development (R&D).

2018 Access to Medicine Index (post)

The 2018 Access to Medicine Index finds that a handful of pharmaceutical companies are developing the bulk of urgently needed new medicines for the poor.